Literature DB >> 22427129

Variables associated with stress ulcer prophylaxis misuse: a retrospective analysis.

Iyad A Issa1, Ola Soubra, Hania Nakkash, Lama Soubra.   

Abstract

BACKGROUND: Stress ulcer prophylaxis (SUP) is commonly used in hospitals. Although its indications are better delineated for intensive care unit (ICU) patients, its use in non-ICU settings is somewhat arbitrary and based on judgment.
OBJECTIVE: We attempted to assess the extent of SUP overuse in our hospital. We also carefully collected and analyzed several variables to detect associations governing this flawed behavior and its financial burden on the hospital's budget.
MATERIALS AND METHODS: We retrospectively analyzed charts of patients admitted to the medical floor of a tertiary referral university hospital over a 1 year period. All adult patients admitted to the medical ward who received at least one dose of SUP were included and reviewed for a multitude of variables in addition to the appropriateness of acid suppression therapy (AST).
RESULTS: We included 320 charts and found that 92% of patients admitted during that period were not eligible for SUP. The total inappropriateness of SUP was noted to be 58% (p = 0.015). Increasing age and male gender were found to be significant variables in AST misuse (p = 0.045 and p = 0.010), much like duration of hospital stay (p = 0.008). Comorbidities was also found to be a defining variable for AST overuse (odds ratio [OR] = 3.27). Patients with two or more minor risk factors were also subjected more to SUP inappropriately (OR = 3.53), in addition to patients of certain specialties (Neurology, Infectious Diseases, etc.). Our calculated financial burden was more than $23,000 per year for the medical floor.
CONCLUSION: This retrospective study confirmed the growing suspicion that SUP misuse is evident on the medical floors. We also delineated several factors and variables associated with and affecting SUP overuse.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22427129     DOI: 10.1007/s10620-012-2104-9

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  44 in total

1.  The rates of common adverse events reported during treatment with proton pump inhibitors used in general practice in England: cohort studies.

Authors:  R M Martin; N R Dunn; S Freemantle; S Shakir
Journal:  Br J Clin Pharmacol       Date:  2000-10       Impact factor: 4.335

2.  Clostridium difficile infection in hospitals: risk factors and responses.

Authors:  Thomas J Louie; Jon Meddings
Journal:  CMAJ       Date:  2004-07-06       Impact factor: 8.262

3.  Bleeding and pneumonia in intensive care patients given ranitidine and sucralfate for prevention of stress ulcer: meta-analysis of randomised controlled trials.

Authors:  A Messori; S Trippoli; M Vaiani; M Gorini; A Corrado
Journal:  BMJ       Date:  2000-11-04

4.  What factors predict potentially inappropriate primary care prescribing in older people? Analysis of UK primary care patient record database.

Authors:  Iain M Carey; Stephen De Wilde; Tess Harris; Christina Victor; Nicky Richards; Sean R Hilton; Derek G Cook
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

Review 5.  Stress-induced ulcer bleeding in critically ill patients.

Authors:  Tauseef Ali; Richard F Harty
Journal:  Gastroenterol Clin North Am       Date:  2009-06       Impact factor: 3.806

6.  Intravenous proton pump inhibitor use in hospital practice.

Authors:  Eoin Slattery; Ruben Theyventhiran; Garret Cullen; Fionnula Kennedy; Carol Ridge; Karen Nolan; Rachel Kidney; Diarmuid P O'Donoghue; Hugh E Mulcahy
Journal:  Eur J Gastroenterol Hepatol       Date:  2007-06       Impact factor: 2.566

Review 7.  When should stress ulcer prophylaxis be used in the ICU?

Authors:  Jean-Pierre Quenot; Nadiejda Thiery; Saber Barbar
Journal:  Curr Opin Crit Care       Date:  2009-04       Impact factor: 3.687

Review 8.  Stress ulcer prophylaxis in hospitalized patients not in intensive care units.

Authors:  Rebekah R Arthur Grube; D Byron May
Journal:  Am J Health Syst Pharm       Date:  2007-07-01       Impact factor: 2.637

9.  Appropriate proton pump inhibitor use among older adults: a retrospective chart review.

Authors:  Claudene J George; Beatriz Korc; Joseph S Ross
Journal:  Am J Geriatr Pharmacother       Date:  2008-12

10.  Inappropriate Use of Intravenous PPI for Stress Ulcer Prophylaxis in an Inner City Community Hospital.

Authors:  Muhammad K Perwaiz; Gerald Posner; Fadi Hammoudeh; Frances Schmidt; Narayan Neupane; Danilo Enriquez; Neerja Gulati
Journal:  J Clin Med Res       Date:  2010-10-11
View more
  11 in total

1.  The Italian Society of Internal Medicine choosing wisely campaign.

Authors:  Nicola Montano; Giorgio Costantino; Giovanni Casazza; Rodolfo Sbrojavacca; Marco Vincenzo Lenti; Lorenzo Falsetti; Annasanta Guzzo; Raffaele Majo; Francesco Perticone; Gino Roberto Corazza
Journal:  Intern Emerg Med       Date:  2016-11-01       Impact factor: 3.397

Review 2.  Stress ulcer prophylaxis, thromboprophylaxis and coagulation management in patients with hip fractures.

Authors:  Heinrich Wolfgang Thaler; Peter Dovjak; Bernhard Iglseder; Georg Pinter; Ernst Müller; Walter Müller; Katharina Pils; Peter Mikosch; Inge Gerstorfer; Michaela Zmaritz; Monique Weissenberger-Leduc; Markus Gosch
Journal:  Wien Med Wochenschr       Date:  2013-09-04

3.  Appropriateness and Associated Factors of Stress Ulcer Prophylaxis for Surgical Inpatients of Orthopedics Department in a Tertiary Hospital: A Cross-Sectional Study.

Authors:  Haiyan Li; Ning Li; Xiaoni Jia; Yuyao Zhai; Xiaorong Xue; Yi Qiao
Journal:  Front Pharmacol       Date:  2022-06-02       Impact factor: 5.988

4.  Assessment of pharmacologic prophylaxis use against stress ulcer in the medical wards of University of Gondar Hospital.

Authors:  Boressa Adugna Horsa; Yohanes Ayele; Mohammed Biset Ayalew
Journal:  SAGE Open Med       Date:  2019-02-02

Review 5.  Use of proton pump inhibitors for the provision of stress ulcer prophylaxis: clinical and economic consequences.

Authors:  Jeffrey F Barletta; David A Sclar
Journal:  Pharmacoeconomics       Date:  2014-01       Impact factor: 4.981

6.  Attachment to stress ulcer prophylaxis guideline in the neurology wards of two teaching and non-teaching hospitals: A retrospective survey in Iran.

Authors:  Farzaneh Foroughinia; Mohammad Madhooshi
Journal:  J Res Pharm Pract       Date:  2016 Apr-Jun

7.  Variables Associated with Adherence to Stress Ulcer Prophylaxis in Patients Admitted to the General Hospital Wards: A Prospective Study.

Authors:  Shadi Farsaei; Sajad Ghorbani; Payman Adibi
Journal:  Adv Pharm Bull       Date:  2017-04-13

8.  Identifying Risk Factors Associated with Inappropriate Use of Acid Suppressive Therapy at a Community Hospital.

Authors:  Amandeep Singh; Vijay Bodukam; Kirit Saigal; Jaya Bahl; Yvette Wang; Alexandra Hanlon; Yinghui Lu; Michael Davis
Journal:  Gastroenterol Res Pract       Date:  2016-10-12       Impact factor: 2.260

9.  Adherence to stress-related mucosal damage prophylaxis guideline in patients admitted to the Intensive Care Unit.

Authors:  Niloofar Rafinazari; Saeed Abbasi; Shadi Farsaei; Marjan Mansourian; Peyman Adibi
Journal:  J Res Pharm Pract       Date:  2016 Jul-Sep

Review 10.  Effective and safe proton pump inhibitor therapy in acid-related diseases - A position paper addressing benefits and potential harms of acid suppression.

Authors:  Carmelo Scarpignato; Luigi Gatta; Angelo Zullo; Corrado Blandizzi
Journal:  BMC Med       Date:  2016-11-09       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.